Spire Wealth Management Harrow Health, Inc. Transaction History

Spire Wealth Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$14.03 - $22.08 $72,380 - $113,910	-5,159 Reduced 55.3%	4,170 $59,000
Q2 2023 Aug 09, 2023	BUY	$17.37 - $28.08 $1,858 - $3,004	107 Added 1.16%	9,329 $177,000
Q1 2023 May 09, 2023	BUY	$13.84 - $21.46 $127,632 - $197,904	9,222 New	9,222 $195,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.